Benchmark reiterated their hold rating on shares of RXO (NYSE:RXO - Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports.
Other analysts have also issued reports about the stock. Susquehanna reduced their price objective on shares of RXO from $16.00 to $12.00 and set a "negative" rating for the company in a research note on Tuesday, November 12th. Citigroup downgraded RXO from a "buy" rating to a "neutral" rating and set a $33.00 price objective for the company. in a research note on Tuesday, November 12th. Oppenheimer reissued an "outperform" rating and issued a $31.00 price target on shares of RXO in a research report on Tuesday, September 17th. Jefferies Financial Group lowered their price objective on shares of RXO from $33.00 to $30.00 and set a "buy" rating on the stock in a research report on Friday, January 10th. Finally, The Goldman Sachs Group reiterated a "neutral" rating and issued a $29.00 target price on shares of RXO in a research report on Monday, November 18th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $26.77.
View Our Latest Report on RXO
RXO Price Performance
NYSE:RXO traded up $0.26 during trading hours on Wednesday, reaching $25.24. 1,010,046 shares of the company's stock were exchanged, compared to its average volume of 925,472. The company has a market capitalization of $4.06 billion, a P/E ratio of -12.75, a price-to-earnings-growth ratio of 15.82 and a beta of 1.52. RXO has a 12 month low of $18.75 and a 12 month high of $32.82. The business's 50-day simple moving average is $27.02 and its two-hundred day simple moving average is $27.82. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.21.
RXO (NYSE:RXO - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.01. The business had revenue of $1.04 billion for the quarter, compared to analysts' expectations of $956.19 million. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. The company's quarterly revenue was up 6.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.05 EPS. Sell-side analysts expect that RXO will post 0.12 EPS for the current fiscal year.
Hedge Funds Weigh In On RXO
Several hedge funds and other institutional investors have recently added to or reduced their stakes in RXO. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in shares of RXO by 407.0% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company's stock worth $43,000 after buying an additional 1,445 shares during the period. Harbor Capital Advisors Inc. bought a new stake in RXO during the fourth quarter valued at about $2,004,000. JPMorgan Chase & Co. grew its position in shares of RXO by 71.8% in the third quarter. JPMorgan Chase & Co. now owns 272,062 shares of the company's stock valued at $7,618,000 after purchasing an additional 113,685 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of RXO by 11.3% in the third quarter. Principal Financial Group Inc. now owns 650,222 shares of the company's stock worth $18,206,000 after purchasing an additional 66,159 shares during the period. Finally, Franklin Resources Inc. acquired a new position in shares of RXO during the 3rd quarter worth about $22,344,000. Institutional investors and hedge funds own 92.73% of the company's stock.
About RXO
(
Get Free Report)
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Featured Articles
Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.